ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
13 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
628
|
224K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
21 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
628
|
224K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
17 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
628
|
224K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
26 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
628
|
224K
|
26
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
adherent
|
151 |
45K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
151
|
45K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
adherent
|
151 |
45K |
36 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
151
|
45K
|
36
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
adherent
|
151 |
45K |
10 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
151
|
45K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
adherent
|
151 |
45K |
0 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
151
|
45K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
adherent
|
151 |
45K |
0 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
151
|
45K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Competition
|
|
adherent
|
15 |
4.9K |
5 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
15
|
4.9K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
adherent
|
75 |
25K |
23 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
75
|
25K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
adherent
|
75 |
25K |
20 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
75
|
25K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
adherent
|
75 |
25K |
12 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
75
|
25K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
My second favourite molecule
|
|
adherent
|
2 |
863 |
5 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
2
|
863
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
12 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
adherent
|
218 |
72K |
46 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
218
|
72K
|
46
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
adherent
|
218 |
72K |
41 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
72K
|
41
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
adherent
|
218 |
72K |
34 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
72K
|
34
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
adherent
|
237 |
73K |
12 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
237
|
73K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
2 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
adherent
|
974 |
309K |
12 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
974
|
309K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
The interview...and maybe, just maybe a Mozz bonus (or two!)
|
|
adherent
|
23 |
9.4K |
20 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
23
|
9.4K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
PAR - Big Deal
|
|
adherent
|
23 |
9.5K |
0 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
23
|
9.5K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR - Big Deal
|
|
adherent
|
23 |
9.5K |
8 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
23
|
9.5K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
adherent
|
73 |
32K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
73
|
32K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
adherent
|
73 |
32K |
14 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
73
|
32K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
adherent
|
73 |
32K |
60 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
73
|
32K
|
60
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
1 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
11 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
22 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
22
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
18 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
18
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
2 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
628
|
224K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
No. of patients treated so far
|
|
adherent
|
7 |
2.7K |
8 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
7
|
2.7K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Reports Phase 3 Clinical Trial Update
|
|
adherent
|
47 |
17K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
47
|
17K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
The Miracles of iPPS on MPS - Part 3
|
|
adherent
|
17 |
7.5K |
8 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
17
|
7.5K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
What do YOU choose?
|
|
adherent
|
51 |
18K |
10 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
51
|
18K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
What do YOU choose?
|
|
adherent
|
51 |
18K |
22 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
51
|
18K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
adherent
|
628 |
224K |
9 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
628
|
224K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Kumagai, one of the Fantastic Four and some Mozz Firsts...
|
|
adherent
|
51 |
15K |
15 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
51
|
15K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Take a deep breath
|
|
adherent
|
87 |
28K |
29 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
87
|
28K
|
29
|
|
ASX - By Stock
|
PAR |
Re:
The Lysosomal Connection...
|
|
adherent
|
9 |
2.7K |
17 |
14/05/23 |
14/05/23 |
ASX - By Stock
|
9
|
2.7K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
adherent
|
4.0K |
1.8M |
24 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
24
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
adherent
|
386 |
160K |
11 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
386
|
160K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
The Load Bearing Molecule
|
|
adherent
|
26 |
7.3K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
26
|
7.3K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The Load Bearing Molecule
|
|
adherent
|
26 |
7.3K |
22 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
26
|
7.3K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
adherent
|
386 |
160K |
5 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
386
|
160K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the BML findings
|
|
adherent
|
31 |
9.7K |
27 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
31
|
9.7K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Needs you!
|
|
adherent
|
79 |
32K |
10 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
79
|
32K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Needs you!
|
|
adherent
|
79 |
32K |
6 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
79
|
32K
|
6
|
|